Fasting
Intermittent Fasting: What You Need to Know
Discover how intermittent fasting works, who it may help, and what research says about safety and results. Not medical advice—consult your doctor first.
- Published
Key Takeaways
- A 2025 clinical trial published in Annals of Internal Medicine found that 4:3 intermittent fasting (fasting three days per week) produced greater weight loss at 12 months compared to daily calorie restriction alone (PMID 42296520).
- A scoping review in Advances in Nutrition found that intermittent fasting generally preserved fat-free (muscle) mass in middle-aged and older adults, though evidence varied by fasting protocol and individual factors (PMID 42463249).
- A meta-analysis in Nutrients found that IF's effects on body composition and cardiometabolic markers differed by age group, suggesting that one-size-fits-all recommendations may not be appropriate (PMID 42280443).
- Emerging Research suggests intermittent fasting may positively influence gut microbiome diversity, which is linked to metabolic health, though more human studies are needed (PMID 42293192).
- Digital tools such as apps and wearables are increasingly used to support fasting adherence, but evidence on their long-term effectiveness for obesity management is still developing (PMID 42310647).
What is intermittent fasting and how does it work?
**Intermittent fasting (IF) is an eating pattern that cycles between set periods of eating and fasting — it focuses on when you eat, not what you eat. **** Rather than eliminating specific foods, IF works by establishing regular periods without calorie intake, which triggers metabolic changes that may support weight loss and overall health.
The core idea: timing your eating window
During a fasting period, your body depletes stored sugar (glycogen) and then shifts to burning stored fat for energy. This metabolic switch is a key reason IF is studied as a weight-management tool. Research published in JAMA Internal Medicine found that a 4:3 fasting schedule (fasting three days per week, eating normally the other four) produced meaningful weight loss over 12 months compared to daily calorie restriction alone.
Common IF schedules
| Schedule | What you do | Good to know |
|---|---|---|
| 16:8 | Fast for 16 hours; eat within an 8-hour window daily | The most widely used approach |
| Time-restricted eating (TRE) | Eating confined to a set clock window (e.g., 8 a.m.–4 p.m.) | Studies are exploring TRE with and without calorie reduction |
| 4:3 | Eat normally 4 days; fast or eat very little 3 non-consecutive days | Shown feasible even in medically complex populations |
| 5:2 | Eat normally 5 days; restrict calories sharply 2 days | A variation of the 4:3 model |
What happens in your body during a fast
- Blood sugar and insulin levels drop, encouraging your body to access fat stores for fuel.
- Gut bacteria may shift beneficially. One review found that intermittent fasting can increase gut microbe diversity, which is linked to better metabolic health.
- Body composition can improve. A scoping review found that IF may help preserve fat-free mass (muscle and bone) during weight loss, though results vary by age and fasting type.
- Cardiometabolic markers — blood pressure, blood fats, and blood sugar — may improve alongside weight loss, according to a systematic review and meta-analysis of randomized controlled trials.
Why this matters if you're taking a GLP-1 medication
GLP-1 medications already reduce appetite and slow digestion. Pairing them with a structured eating window may reinforce those effects — but the combination raises important questions about meal timing, nutrient intake, and muscle preservation that warrant discussion with your care team.
This content is for general information only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before starting or changing any fasting or medication plan.
What does recent Research say about weight loss results?
Recent studies show that combining intermittent fasting with structured lifestyle changes can produce meaningful weight loss — and that how you fast may matter as much as whether you fast.
What the numbers look like
A large randomized controlled trial comparing a 4:3 fasting pattern (three non-consecutive fasting days per week) against standard daily calorie restriction found that at 12 months, the 4:3 fasting group lost more weight than the daily calorie-cutting group. This suggests that structured fasting days may give some people an advantage over simply eating less every day.
Who tends to benefit — and how much
A systematic review and meta-analysis found that intermittent fasting produced meaningful reductions in body weight, body fat percentage, and waist circumference across adults of different ages. However, the size of the benefit varied by age group, with younger adults sometimes seeing larger changes in certain markers.
A real concern: protecting muscle
Weight loss isn't only about the number on the scale — losing muscle alongside fat can slow your metabolism and affect long-term health. A scoping review found that evidence on whether intermittent fasting preserves or reduces fat-free mass (muscle, bone, and organ tissue) in middle-aged and older adults is still mixed and needs more study. This is especially relevant if you're using a GLP-1 medication, since these drugs can accelerate overall weight loss — making adequate protein intake and resistance exercise even more important.
Time-restricted eating alongside other approaches
Research is also exploring how time-restricted eating (limiting food intake to a set window each day, such as 8 hours) compares to medication-based approaches. One ongoing trial is directly comparing an early time-restricted Mediterranean diet to a prescription weight-loss medication (source) for people with cardiometabolic risk factors. Results from studies like this will help clarify where fasting fits alongside drug therapy.
The bottom line from the evidence so far:
- Structured fasting patterns, particularly 4:3, show promising weight loss results at 12 months
- Benefits vary by age and individual factors
- Muscle preservation remains an open question that deserves attention
- Head-to-head comparisons with medications are still emerging
This content is for general informational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare provider before starting or changing any fasting, diet, or medication plan.
How does intermittent fasting affect muscle mass and body composition?
Intermittent fasting can help you lose body fat while largely preserving muscle. Still, the outcome depends on several factors — particularly important if you're older or taking GLP-1 medications that already suppress appetite.
What the Research shows about fat loss
Studies consistently demonstrate that intermittent fasting reduces body weight and body fat. A large systematic review and meta-analysis found meaningful reductions in body fat percentage across adults with overweight or obesity, with results varying by age group — meta-analysis of RCTs. A clinical trial comparing 4:3 fasting (three fasting days per week) to daily calorie restriction found significant weight loss at 12 months in the fasting group — 4:3 fasting trial.
The muscle question — and why it matters for GLP-1 users
"Fat-free mass" includes everything in your body that isn't fat: muscle, bone, and water. Preserving it matters because muscle maintains your metabolism and physical strength. A scoping review of middle-aged and older adults found that intermittent fasting generally preserved fat-free mass, though results varied by fasting type, protein intake, and whether resistance exercise was included — scoping review on fat-free mass.
This is especially relevant if you take GLP-1 medication, since these drugs dramatically reduce appetite. Insufficient protein or overall food intake increases the risk of losing muscle alongside fat.
Key factors that protect muscle during fasting:
- Protein intake: Prioritize protein-rich foods during your eating window to provide muscles with essential amino acids
- Resistance exercise: Strength training signals your body to preserve muscle even in a calorie deficit
- Age awareness: Older adults require extra attention to protein and exercise, as muscle loss becomes more likely with age — scoping review on fat-free mass
- Fasting structure: Extreme or very long fasting windows may increase muscle loss risk more than moderate approaches like 16:8 or 4:3
The bottom line for GLP-1 users
Combining GLP-1 medication with intermittent fasting can effectively improve body composition — losing fat while preserving muscle — but requires intentional effort. Since GLP-1 medications already reduce appetite, the quality of food during your eating window becomes more critical than quantity.
This content is for general informational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always consult your doctor, registered dietitian, or qualified healthcare provider before making changes to your diet, medication, or exercise routine.
Who should be especially cautious about intermittent fasting?
Intermittent fasting is not right for everyone — and for some people, it carries real risks that outweigh the benefits. If any of the groups below apply to you, talk with your doctor or care team before starting or continuing a fasting routine alongside your GLP-1 medication. **
People who should take extra care or avoid intermittent fasting entirely:
-
Older adults concerned about muscle loss. As we age, our bodies are less efficient at building and maintaining muscle. ** A scoping review on fasting and muscle mass found that intermittent fasting in middle-aged and older adults can reduce fat-free mass — meaning muscle, not just fat, may be lost. ** Since GLP-1 medications also reduce overall body weight quickly, older adults face a compounded risk of losing muscle needed for strength, balance, and independence.
-
People with a history of depression or other mental health conditions. Restricting eating windows can affect mood, energy, and your relationship with food. ** A clinical trial protocol studying fasting in people with major depression and obesity flags this population as needing careful monitoring, because calorie restriction and rigid eating schedules may worsen depressive symptoms in some people. **
-
Cancer survivors, especially those with breast cancer. A feasibility study on fasting in breast cancer survivors notes that this group requires close safety monitoring due to their nutritional needs and treatment histories, which can make standard fasting protocols risky without medical supervision.
-
People with liver disease or significant cardiometabolic risk. A randomized trial (the MEDFAST trial) studying time-restricted eating in people with liver fibrosis underscores that fasting in this group must be medically supervised, since the liver plays a central role in managing fasting-state metabolism.
-
**Anyone with a history of disordered eating. **** Structured fasting schedules can trigger restrictive thinking patterns. This isn't a reason to never consider fasting, but it is a reason to involve a registered dietitian or therapist before starting.
-
Younger adults and those with low body weight. A meta-analysis of fasting across age groups found that body composition responses to fasting differ meaningfully by age and baseline weight — meaning a plan that works safely for one person may not be appropriate for another.
The bottom line: fasting is a tool, not a universal prescription. Your care team can help you weigh the benefits against your personal health history.
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your diet, medication, or health routine.
Can digital tools help you stick to a fasting plan?
Yes — digital tools can meaningfully support fasting adherence. Research suggests they are a practical addition to any structured fasting plan. Apps, wearables, and online programs help you track fasting windows, log meals, and stay accountable—factors linked to better long-term results.
A scoping review of digital interventions for obesity management found that technology-based tools, including smartphone apps, web platforms, and remote monitoring devices, were associated with improved engagement and weight-related outcomes in adults managing obesity. People who used digital support tended to stay on track longer than those going it alone.
Here is what the evidence suggests these tools do well:
- Fasting window tracking. Apps that let you set a timer for your eating window (for example, an 8-hour window in a 16:8 plan) remove the guesswork. Some also send reminders when your fast is about to begin or end, reducing the chance of accidentally breaking a fast too early.
- Meal and calorie logging. Clinical fasting trials use digital food diaries as a core part of their protocol. A randomized trial on time-restricted eating incorporated structured dietary tracking as part of its intervention design, reflecting how central logging is to measuring and maintaining adherence.
- Remote check-ins and coaching. A breast cancer survivor fasting feasibility trial built in digital communication between participants and study staff, showing that remote support is both acceptable and practical for people following structured fasting programs.
- Progress monitoring. Tracking weight, energy levels, or other markers over time helps you and your healthcare team spot patterns—for example, whether a particular fasting schedule is affecting your energy or appetite on GLP-1 medication days. **
A note on GLP-1 medications specifically: GLP-1 drugs reduce appetite by mimicking a natural gut hormone, which can make it harder to notice whether you are eating enough during your eating window. A digital food log is especially useful here—it provides a concrete record to review with your doctor or dietitian, rather than relying on hunger cues alone.
Practical tip: Look for apps that allow you to export or share your data. Bringing a simple summary to your next appointment gives your care team real information to work with.
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing a fasting plan, especially if you are taking medication.
What should you discuss with your doctor before starting?
Before combining a GLP-1 medication with any fasting plan, discuss your approach with your prescribing doctor or a registered dietitian. This conversation helps you avoid serious side effects and ensures safety for your specific health situation.
Your current medications and dosing schedule
GLP-1 medications slow digestion and reduce appetite. Adding fasting can further lower calorie and nutrient intake. Tell your doctor which fasting pattern you're considering—for example, 4:3 fasting means eating normally four days a week and restricting calories on three non-consecutive days (PMID 42296520). Your dose or timing may need adjustment.
Your personal health history—especially these conditions
Some health situations require extra caution or make certain fasting approaches unsuitable:
- Depression or mental health conditions: Research into fasting protocols screens for and monitors mood changes (PMID 42363285). Disclose any history of depression, anxiety, or disordered eating.
- Liver health concerns: Fasting combined with metabolic risk factors (high blood pressure, high blood sugar, or high cholesterol) is being studied for effects on liver tissue (MEDFAST trial, PMID 42350004). Disclose any known liver issues.
- Cancer history: Clinical trials studying fasting in cancer survivors require careful medical screening before enrollment (PMID 42492498). A cancer history warrants an individualized conversation.
- Age and muscle mass: Fasting can affect lean muscle. Older adults may be at greater risk of losing muscle during calorie restriction (PMID 42463249). Ask whether you need extra protein or resistance exercise in your plan.
How you'll be monitored
Ask your doctor about follow-up care. Research programs studying fasting and metabolic health track participants' weight, blood markers, and body composition over time (PMID 42280443). You deserve regular check-ins, even outside a clinical trial.
Your goals and what success means to you
Be honest about why you want to fast—weight loss, blood sugar control, energy, or another reason. Your doctor can help you set realistic, measurable targets and adjust expectations if needed.
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any diet, medication, or health program.
FAQ
What is 4:3 intermittent fasting?
4:3 intermittent fasting involves eating normally on four days of the week and significantly restricting calories—or fasting entirely—on the other three non-consecutive days. A 2025 trial in Annals of Internal Medicine studied this approach and found it led to greater weight loss at 12 months compared to daily calorie restriction (PMID 42296520). Individual results vary, and this approach may not be suitable for everyone.
Will intermittent fasting cause me to lose muscle?
A scoping review in Advances in Nutrition found that most intermittent fasting protocols did not significantly reduce fat-free mass (muscle) in middle-aged and older adults. However, results depended on the specific protocol, protein intake, and physical activity levels (PMID 42463249). Speak with a healthcare provider or registered dietitian to understand how fasting might affect your individual body composition.
Is intermittent fasting safe for breast cancer survivors?
Researchers are actively studying this question. A feasibility trial protocol published in JMIR Research Protocols is investigating the safety and acceptability of 4:3 intermittent fasting specifically in Stage I–III breast cancer survivors with overweight or obesity (PMID 42492498). Because this Research is ongoing, cancer survivors should consult their oncology team before attempting any fasting regimen.
Can intermittent fasting help with depression or mental health?
A randomized controlled trial protocol published in Trials is currently investigating whether time-restricted eating—with or without calorie restriction—affects depression scores in people with major depressive disorder and obesity (PMID 42363285). Results from this trial are not yet available so that no conclusions can be drawn. Anyone managing depression should work closely with a mental health professional before changing their diet.
Does intermittent fasting affect gut health?
A review in Frontiers in Nutrition found that Ramadan-style intermittent fasting was associated with changes in gut microbiome diversity and composition, with potential implications for metabolic health (PMID 42293192). However, Research in this area is still emerging, and it is not yet clear how different fasting protocols affect the gut microbiome over the long term.
Are there apps or digital tools that can support intermittent fasting?
A scoping review in BMC Public Health found that digital interventions—including apps, wearables, and online platforms—are increasingly used to support adult obesity management, including fasting-based approaches (PMID 42310647). While these tools may help with tracking and motivation, the evidence on their long-term effectiveness is still limited. They are best used as a complement to, not a replacement for, professional medical guidance.
This article is for general information and is not medical advice. GLP-1 medications are prescription drugs, and fasting is not right for everyone — talk to a licensed healthcare provider before starting, stopping, or changing any treatment or eating pattern.
Sources
Where this comes from
- Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial.
- Intermittent Fasting and Fat-Free Mass Outcomes in Middle-Aged and Older Adults: A Scoping Review.
- Investigating the effect of intermittent fasting (time-restricted eating) with and without calorie restriction compared to calorie restriction on anthropometric parameters, depression score, and metabolic factors in patients with major depression disorder and obesity: a study protocol for a randomized controlled trial.
- Effect of an early time restricted eating Mediterranean diet compared to naltrexone/bupropion on liver fibrosis in people with cardiometabolic risk factors in a hospital outpatient clinic: study protocol for a randomised controlled trial (MEDFAST trial).
- Integration technology into health care: a scoping review of digital interventions for adult obesity management.
- The Effect of 4:3 Intermittent Fasting on Weight Loss at 12 Months.
- Ramadan intermittent fasting and the gut microbiome: modulation of diversity and implications for metabolic health.
- Age-Specific Analysis of the Effects of Intermittent Fasting on Body Composition and Cardiometabolic Markers in Healthy Adults and Individuals with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
This article is educational, not medical advice. GLP-1 therapy and fasting decisions belong in a conversation with a clinician who knows your history.